With great interest, I have read the data published recently by Varoglu and Balkuv. 1 They
raised an interesting clinical question about the outcome and lateralization of clinical …

Objectives: To investigate the importance of the side of clinical findings in predicting the
prognosis in multiple sclerosis (MS) patients. Methods: In our study we enrolled 361 MS …

Background The clinical course of multiple sclerosis (MS) evolves over many years. Its
prognosis is highly variable among affected individuals, ie while some suffer from early …

Background/Objective (s) Diagnosing secondary progressive multiple sclerosis (SPMS)
requires careful examination of the gradual decline that occurs following an initial relapsing …

There are several articles in this special issue in which authors eloquently describe
neurobehavioural and cognitive complications of multiple sclerosis with relevant …

Multiple sclerosis (MS) is a chronic, debilitating, autoimmune-mediated, inflammatory
disease of the central nervous system (CNS), in which a combination of inflammation …

The combination of infratentorial and spinal cord lesions did not result in a higher risk of
disability progression compared to patients with lesions on these locations separately …

BACKGROUND: Daily practice is still faced with uncertainty in predicting the long-term
disability of multiple sclerosis (MS). Most information comes from northern hemisphere …

Background Recent studies suggest that cortical lesions in multiple sclerosis (MS)
substantially contribute to clinical disease severity. The present study aimed at investigating …

To evaluate whether hemispheric lesion distribution in multiple sclerosis is related to the
uneven interhemispheric localisation of cerebral function, a 10 item self administered …